A Single Dose Escalation Study of PCSK9 Inhibitor (JS002) in Health Subjects
Clinical trial NCT04197817 · COMPLETED
Trial details
- NCT number
- NCT04197817
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-11
- Primary completion
- 2018-08-14
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.